Bola-amphiphilic dendrimer empowers imatinib to target metastatic ovarian cancer stem cells via beta-catenin-HRP2 signaling axis
Z. Shi, M. Artemenko, M. Zhang, C. Yi, P. Chen, S. Lin, Z. Bian, B. Lian, F. Meng, J. Chen, T. Roussel, Y. Li, K. K. L. Chan, P. P. C. Ip, H.-C. Lai, , A. S.-T. Wong
This study develops a nanoformulation Bola/IM to target metastatic ovarian cancer stem cells via the beta-catenin-HRP2 signaling axis, showing improved efficacy and synergy with cisplatin.
bioRxiv · Jun 7, 2024 · PreprintCancer Biology